IRIS- DESyne X2 in the IRIS-DES Registry

Launched by SEUNG-JUNG PARK · Jul 5, 2018

Keywords

ClinConnect Summary

The IRIS-DESyne X2 clinical trial is studying the effectiveness and safety of a specific heart stent called the DeSyne X2. This stent is used to treat conditions related to narrowed or blocked coronary arteries, which can lead to heart disease. The trial is currently looking for participants aged 19 and older who are willing to provide written consent to join the study. However, those who have a very short life expectancy, are in cardiac shock, or are receiving other similar stents at the same time are not eligible to participate.

If you decide to join this trial, you will receive the DeSyne X2 stent as part of your treatment. The main goal of the study is to see how well this stent works in everyday clinical practice and to ensure it is safe for patients like you. Your participation could help provide valuable information for future patients with similar heart conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 19 and more
• • Intervention with DeSyne X2 drug-eluting coronary stent
• • Agreed with written informed consent form
• Exclusion Criteria:
• • Intervention with DeSyne X2 drug-eluting coronary stent and other drug eluting stent at the same time
• • Life expectancy of 1year and under
• • Cardiac shock